LEXICON PHARMACEUTICALS, INC. Quarterly Cash and Cash Equivalents, Period Increase (Decrease) in USD from Q1 2011 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
Summary
Lexicon Pharmaceuticals, Inc. annual/quarterly Cash and Cash Equivalents, Period Increase (Decrease) history and growth rate from Q1 2011 to Q1 2022.
  • Lexicon Pharmaceuticals, Inc. Cash and Cash Equivalents, Period Increase (Decrease) for the quarter ending March 31, 2022 was -$4.55M, a 84.1% increase year-over-year.
  • Lexicon Pharmaceuticals, Inc. annual Cash and Cash Equivalents, Period Increase (Decrease) for 2022 was -$17.7M, a 71.5% increase from 2021.
  • Lexicon Pharmaceuticals, Inc. annual Cash and Cash Equivalents, Period Increase (Decrease) for 2021 was -$62.2M, a 169% decline from 2020.
  • Lexicon Pharmaceuticals, Inc. annual Cash and Cash Equivalents, Period Increase (Decrease) for 2020 was $90.2M.
Cash and Cash Equivalents, Period Increase (Decrease), Quarterly (USD)
Cash and Cash Equivalents, Period Increase (Decrease), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 -$4.55M +$24.1M +84.1% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q1 2021 -$28.6M -$48.1M -247% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $19.5M +$54.1M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 -$34.6M +$6.63M +16.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-27
Q1 2018 -$41.2M +$2.91M +6.58% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q1 2017 -$44.1M +$134M +75.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q1 2016 -$178M -$83M -87.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q1 2015 -$95.3M -$104M -1157% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q1 2014 $9.02M +$5.19M +136% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q1 2013 $3.83M +$161M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q1 2012 -$157M -$130M -481% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q1 2011 -$27.1M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.